by last | Mar 17, 2022 | 2022, Past Events
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”by last | Mar 15, 2022 | Past Events
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions: emerging clinical data in glioblastoma, sarcoma and dermato-oncology indications”. Please follow the link below for more information PEGS 2022...by last | Mar 15, 2022 | 2022, Past Events
Philogen is presenting a ePoster entitled “A novel tumor-targeting cytokine-based therapy in combination with lomustine displays promising anti-tumor activity against glioblastoma” Please follow the link below for more information WFNOS 2022...by last | Mar 15, 2022 | 2022, Past Events
Philogen announces its attendance at the 12th Annual World ADC London 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in...by last | Mar 15, 2022 | 2022, Past Events
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-Cytokine Fusions: from the bench to the clinic”.by last | Mar 15, 2022 | 2022, Past Events
Philogen announces its attendance at the AACR Annual Meeting on April 8-13, 2022. Aureliano Zana, 3rd year PhD student at Philogen, is presenting an ePoster entitled “Fibroblast Activation Protein triggers release of drug payload from non-internalizing small...